Pablo Hernáiz-Driever
21PUBLICATIONS
106CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (21)
Sort by Publication Date:
|Jan 27, 2026
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).Pablo Hernáiz Driever, Uwe R Kordes, Ines B Brecht
|Apr 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford
|Jul 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.Britt A E Dhaenens, Günter Heimann, Annette Bakker
|May 20, 2024
Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens.Michèle Simon, Luis P Kuschel, Katja von Hoff
|Mar 12, 2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford
|Nov 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford
Pageof 4
Frequent Collaborators
5 joint publications
Astrid Katharina Gnekow
5 joint publications
David Capper
5 joint publications
Jordan R Hansford
5 joint publications
Nicholas G Gottardo
4 joint publications
David S Ziegler
4 joint publications
Uwe R Kordes
4 joint publications
Nada Jabado
4 joint publications
Nicolas U Gerber
3 joint publications
Daniela Kandels
3 joint publications
Gudrun Fleischhack
